CCL2 and early-onset autosomal dominant Alzheimer disease: Moreover, MCP-1 is also considered a biomarker of chronic inflammation in Alzheimer’s disease [63] and its expression has been associated with increased oxidative stress production, suggesting the pivotal role this chemokine plays in the inflammatory processes, as well as in several pathological conditions [62].